TY  - JOUR

T1  - LONG-TERM EFFICACY OF ABROCITINIB AS MONOTHERAPY OVER 96 WEEKS IN THE JADE CLINICAL PROGRAM

JO  - Annals of Allergy, Asthma & Immunology

UR  - http://dx.doi.org/10.1016/j.anai.2024.08.321

PY  - 2024/11/01

AU  - Geng B

AU  - Simpson E

AU  - Gooderham M

AU  - Gupta M

AU  - Deleuran M

AU  - Cork M

AU  - Biswas P

AU  - Koppensteiner H

ED  - 

DO  - DOI: 10.1016/j.anai.2024.08.321

PB  - Elsevier BV

VL  - 133

IS  - 6

SP  - S100

EP  - S100

Y2  - 2024/12/22

ER  -